Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-25 | 100.17 | n/a | 1.24p | 38.2 | n/a | -67% | 4.45p | 0.0% |
30-Jun-26 | 110.19 | n/a | 1.69p | 28.1 | 0.8 | +36% | 4.45p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
---|---|---|---|---|---|---|
Revenue (£m) | ||||||
30-Jun-2025 | 100 | n/a | n/a | 83 | 83 | 99 |
30-Jun-2026 | 110 | n/a | n/a | 91 | 91 | n/a |
Earnings | ||||||
30-Jun-2025 | 1.24p | n/a | n/a | 1.64p | 1.64p | 3.90p |
30-Jun-2026 | 1.69p | n/a | n/a | 3.12p | 3.12p | n/a |
Dividend | ||||||
30-Jun-2025 | 4.45p | n/a | n/a | 4.45p | 4.45p | 4.45p |
30-Jun-2026 | 4.45p | n/a | n/a | 4.45p | 4.45p | n/a |
Recommendations | ||||||
Strong Buy | 1 | 0 | 1 | 1 | 0 | 0 |
Buy | 1 | 0 | 1 | 1 | 1 | 1 |
Neutral | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Brokers | 2 | 0 | 2 | 2 | 1 | 1 |
Average Rec | 8.75 | n/a | 8.75 | 8.75 | 7.50 | 7.50 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 47.30p |
Change Today | 0.20p |
% Change | 0.42 % |
52 Week High | 53.50 |
52 Week Low | 43.70 |
Volume | 10,857 |
Shares Issued | 137.56m |
Market Cap | £65.06m |
Beta | 0.00 |
RiskGrade | 154 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 13-Mar-25 | 03-Oct-24 |
Paid | 24-Apr-25 | 14-Nov-24 |
Amount | 1.80p | 2.65p |
Time | Volume / Share Price |
13:34 | 10,375 @ 48.15p |
09:24 | 482 @ 48.15p |
Chair | Philip Kay |
CEO | Thomas Morfett |
You are here: research